Letermovir
CAS 917389-32-3
In Stock
Letermovir
Cat. No. ANT-LTM-000CAS 917389-32-3In Stock
Technical Data
Cat. No.ANT-LTM-000
CAS917389-32-3
Mol. FormulaC29H28F4N4O4
Mol. Weight572.6 g/mol
IUPAC2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
SMILESCOC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O
InChIInChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1
InChI KeyFWYSMLBETOMXAG-QHCPKHFHSA-N
Purity99%
Description
Overview
Letermovir is an antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease
Anant Labs manufacture and furnish high quality Letermovir impurities for global markets. Our Letermovir EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
(S)-2-(8-Fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acidLetermovir917389-32-3PrevymisAIC246AIC-246MK-8228AIC 2461H09Y5WO1F2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
